Orbimed Advisors LLC Karyopharm Therapeutics Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $8.94 Million - $17.2 Million	-621,900 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $4.1 Million - $8.73 Million	-444,000 Reduced 41.65%	621,900 $11.9 Million
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $11.8 Million - $24.7 Million	-2,082,575 Reduced 66.15%	1,065,900 $10.3 Million
Q2 2019 Aug 14, 2019	BUY	$4.32 - $6.43 $13.6 Million - $20.2 Million	3,148,475 New	3,148,475 $18.9 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.